Drug Database
Back to search

Poland· PL-100387527

Sylifar

A silymarin product containing silybi mariani extractum siccum raffinatum et normatum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC A05BA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSylifarATCA05BA03REGISTER NO.PL-100387527PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about silybi mariani extractum siccum raffinatum et normatumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Silymarin is registered in 5 of 19 countries.

Countries holding a registration under ATC A05BA03 (silymarin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search silymarin products by name

Silymarin · ATC A05BA03

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Silybi mariani extractum siccum raffinatum et normatum
Manufacturer
Biofarm Sp. z o.o.
Country
Poland (PL)
ATC code
A05BA03
ATC class
Silymarin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991414030
  • gtin
    05909991414047
  • gtin
    05909991414054
  • gtin
    05909991414061
  • gtin
    05909991414078

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A05BA03

Silymarin, as other registers publish it.

All silymarin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c93d80dc-2a54-482d-a413-7ef7d67c9088
GET /v1/drugs/c93d80dc-2a54-482d-a413-7ef7d67c9088?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "140 mg sylimaryny w przeliczeniu na sylibininę",
  "packaging": "05909991414030 ¦ OTC ¦ 134032\n10 kaps.\n05909991414047 ¦ OTC ¦ 134033\n20 kaps.\n05909991414054 ¦ OTC ¦ 134034\n30 kaps.\n05909991414061 ¦ OTC ¦ 134035\n60 kaps.\n05909991414078 ¦ OTC ¦ 134036\n100 kaps.",
  "substance": "Silybi mariani extractum siccum raffinatum et normatum 241.35 mg/kaps.",
  "common_name": "Silybi mariani extractum siccum raffinatum et normatum",
  "pl_product_id": "100387527",
  "pozwolenie_nr": "25685",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-12-30"
}
API referenceMCP serverPlans

See everything about silymarin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console